▶ 調査レポート

世界の美容整形市場(~2027):種類別、手順別、プロバイダー別、地域別

• 英文タイトル:Cosmetic Surgery Market Research Report by Type, Procedure, Provider, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19

360iResearchが調査・発行した産業分析レポートです。世界の美容整形市場(~2027):種類別、手順別、プロバイダー別、地域別 / Cosmetic Surgery Market Research Report by Type, Procedure, Provider, Region - Global Forecast to 2027 - Cumulative Impact of COVID-19 / MRC2302C054資料のイメージです。• レポートコード:MRC2302C054
• 出版社/出版日:360iResearch / 2023年2月3日
• レポート形態:英語、PDF、243ページ
• 納品方法:Eメール(受注後2-3日)
• 産業分類:医療
• 販売価格(消費税別)
  Single User(1名利用、印刷可)¥732,452 (USD4,949)▷ お問い合わせ
  Enterprise License(企業利用、印刷可)¥1,472,452 (USD9,949)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
360iResearch社では、2021年に240.4億ドルであった世界の美容整形市場規模が、2022年に259.5億ドルに達し、2027年には年平均成長率8.14%で384.5億ドルまで成長すると予測しています。当調査レポートでは、美容整形の世界市場の現状について調査・分析し、序論、調査方法、エグゼクティブサマリー、市場概要、市場インサイト、競争状況などの構成でまとめております。セグメント分析では、種類別(ボトックス&フィラー、ブラジリアンバットリフト、豊胸術、バストリフト)、手順別(非外科的処置、外科的処置)、プロバイダー別(病院&専門クリニック、スパ&美容整形センター)、地域別(南北アメリカ、アメリカ、カナダ、ブラジル、アジア太平洋、日本、中国、インド、韓国、台湾、ヨーロッパ/中東/アフリカ、イギリス、ドイツ、フランス、ロシア、その他)の情報が含まれています。なお、当市場の主要企業には、Altra Industrial Motion Corp、Belden Tools, Inc、Dana Incorporated、Eugen Klein GmbH、Gelenkwellenwerk Stadtilm GmbH、GKN Plc、GSP Group、Hindustan Hardy Ltd、Joint shaft factory Stadtilm GmbH、JTEKT Corporation、Meritor, Inc.、MISUMI USA, Inc、Neapco Inc、S.S. White Technologies Inc、Showa Corporation、Spicer Gelenkwellenbau GmbH、Voith Groupなどが含まれています。
・序論
・調査方法
・エグゼクティブサマリー
・市場概要
・市場インサイト

・世界の美容整形市場規模:種類別
- ボトックス&フィラー整形の市場規模
- ブラジリアンバットリフト整形の市場規模
- 豊胸術整形の市場規模
- バストリフト整形の市場規模

・世界の美容整形市場規模:手順別
- 非外科的処置の市場規模
- 外科的処置の市場規模

・世界の美容整形市場規模:プロバイダー別
- 病院&専門クリニックの市場規模
- スパ&美容整形センターの市場規模

・世界の美容整形市場規模:地域別
- 南北アメリカの美容整形市場規模
アメリカの美容整形市場規模
カナダの美容整形市場規模
ブラジルの美容整形市場規模

- アジア太平洋の美容整形市場規模
日本の美容整形市場規模
中国の美容整形市場規模
インドの美容整形市場規模
韓国の美容整形市場規模
台湾の美容整形市場規模

- ヨーロッパ/中東/アフリカの美容整形市場規模
イギリスの美容整形市場規模
ドイツの美容整形市場規模
フランスの美容整形市場規模
ロシアの美容整形市場規模

- その他地域の美容整形市場規模

・競争状況
・企業情報

The Global Cosmetic Surgery Market size was estimated at USD 24.04 billion in 2021 and expected to reach USD 25.95 billion in 2022, and is projected to grow at a CAGR 8.14% to reach USD 38.45 billion by 2027.

Market Statistics:
The report provides market sizing and forecast across 7 major currencies – USD, EUR, JPY, GBP, AUD, CAD, and CHF. It helps organization leaders make better decisions when currency exchange data is readily available. In this report, the years 2018 and 2020 are considered as historical years, 2021 as the base year, 2022 as the estimated year, and years from 2023 to 2027 are considered as the forecast period.

Market Segmentation & Coverage:
This research report categorizes the Cosmetic Surgery to forecast the revenues and analyze the trends in each of the following sub-markets:

Based on Type, the market was studied across Botox and Fillers, Brazilian Butt Lift, Breast Augmentation, Breast Lift, Dermabrasion, Eyelid Surgery, Facelift, Forehead/Brow Lift, Liposuction, Nasal Reshaping, and Tummy Tuck.

Based on Procedure, the market was studied across Non-surgical Procedures and Surgical Procedures. The Non-surgical Procedures is further studied across Botulinum toxin, Dermal Fillers, Laser Hair Removal, Microdermabrasion, and Photo-rejuvenation. The Surgical Procedures is further studied across Breast Augmentation, Breast Lift, Eyelid Surgery, Liposuction, and Tummy Tuck.

Based on Provider, the market was studied across Hospitals & Specialty Clinics and Spas & Cosmetic Surgery Centers.

Based on Region, the market was studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

Cumulative Impact of COVID-19:
COVID-19 is an incomparable global public health emergency that has affected almost every industry, and the long-term effects are projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlying COVID-19 issues and potential paths forward. The report delivers insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecasts, considering the COVID-19 impact on the market.

Cumulative Impact of 2022 Russia Ukraine Conflict:
We continuously monitor and update reports on political and economic uncertainty due to the Russian invasion of Ukraine. Negative impacts are significantly foreseen globally, especially across Eastern Europe, European Union, Eastern & Central Asia, and the United States. This contention has severely affected lives and livelihoods and represents far-reaching disruptions in trade dynamics. The potential effects of ongoing war and uncertainty in Eastern Europe are expected to have an adverse impact on the world economy, with especially long-term harsh effects on Russia.This report uncovers the impact of demand & supply, pricing variants, strategic uptake of vendors, and recommendations for Cosmetic Surgery market considering the current update on the conflict and its global response.

Competitive Strategic Window:
The Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies to help the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. It describes the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth during a forecast period.

FPNV Positioning Matrix:
The FPNV Positioning Matrix evaluates and categorizes the vendors in the Cosmetic Surgery Market based on Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Market Share Analysis:
The Market Share Analysis offers the analysis of vendors considering their contribution to the overall market. It provides the idea of its revenue generation into the overall market compared to other vendors in the space. It provides insights into how vendors are performing in terms of revenue generation and customer base compared to others. Knowing market share offers an idea of the size and competitiveness of the vendors for the base year. It reveals the market characteristics in terms of accumulation, fragmentation, dominance, and amalgamation traits.

Competitive Scenario:
The Competitive Scenario provides an outlook analysis of the various business growth strategies adopted by the vendors. The news covered in this section deliver valuable thoughts at the different stage while keeping up-to-date with the business and engage stakeholders in the economic debate. The competitive scenario represents press releases or news of the companies categorized into Merger & Acquisition, Agreement, Collaboration, & Partnership, New Product Launch & Enhancement, Investment & Funding, and Award, Recognition, & Expansion. All the news collected help vendor to understand the gaps in the marketplace and competitor’s strength and weakness thereby, providing insights to enhance product and service.

Company Usability Profiles:
The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Cosmetic Surgery Market, including Adoderm GmbH, Aerolase Corp., Aesthetic Dermal S.L., Allergan, Inc., Amiea Med, Anteis S.A., BENEV Company Inc., Canfield Imaging Systems, Chromomogenex PLC, Contura International A/S, Cutera, Inc., Genesis Biosystems, Inc., Johnson & Johnson, Syneron Medical Ltd., and Valeant Pharmaceuticals International.

The report provides insights on the following pointers:
1. Market Penetration: Provides comprehensive information on the market offered by the key players
2. Market Development: Provides in-depth information about lucrative emerging markets and analyze penetration across mature segments of the markets
3. Market Diversification: Provides detailed information about new product launches, untapped geographies, recent developments, and investments
4. Competitive Assessment & Intelligence: Provides an exhaustive assessment of market shares, strategies, products, certification, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players
5. Product Development & Innovation: Provides intelligent insights on future technologies, R&D activities, and breakthrough product developments

The report answers questions such as:
1. What is the market size and forecast of the Global Cosmetic Surgery Market?
2. What are the inhibiting factors and impact of COVID-19 shaping the Global Cosmetic Surgery Market during the forecast period?
3. Which are the products/segments/applications/areas to invest in over the forecast period in the Global Cosmetic Surgery Market?
4. What is the competitive strategic window for opportunities in the Global Cosmetic Surgery Market?
5. What are the technology trends and regulatory frameworks in the Global Cosmetic Surgery Market?
6. What is the market share of the leading vendors in the Global Cosmetic Surgery Market?
7. What modes and strategic moves are considered suitable for entering the Global Cosmetic Surgery Market?

レポート目次

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders

2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Technological developments and the presence of skilled surgeons
5.1.1.2. Growing use of social media, increasing disposable income, the popularity of digital photography and self-monitoring app
5.1.1.3. Rising demand by consumers to boost self-esteem
5.1.1.4. Prevalence of skin disorders such as Eczema and Psoriasis
5.1.1.5. Development of advanced materials such as silicone implants
5.1.2. Restraints
5.1.2.1. Non-essential nature of cosmetic surgery
5.1.2.2. Social taboos against violation of body parts
5.1.3. Opportunities
5.1.3.1. Increasing affordability of cosmetic surgeries in developing countries
5.1.3.2. Increasing safety of surgical procedures and growing medical tourism
5.1.4. Challenges
5.1.4.1. Stringent regulatory policies
5.1.4.2. Side effects associated with cosmetic treatments
5.1.4.3. High cost of cosmetic surgeries
5.2. Cumulative Impact of COVID-19

6. Cosmetic Surgery Market, by Type
6.1. Introduction
6.2. Botox and Fillers
6.3. Brazilian Butt Lift
6.4. Breast Augmentation
6.5. Breast Lift
6.6. Dermabrasion
6.7. Eyelid Surgery
6.8. Facelift
6.9. Forehead/Brow Lift
6.10. Liposuction
6.11. Nasal Reshaping
6.12. Tummy Tuck

7. Cosmetic Surgery Market, by Procedure
7.1. Introduction
7.2. Non-surgical Procedures
7.3.1. Botulinum toxin
7.3.2. Dermal Fillers
7.3.3. Laser Hair Removal
7.3.4. Microdermabrasion
7.3.5. Photo-rejuvenation
7.3. Surgical Procedures
7.4.1. Breast Augmentation
7.4.2. Breast Lift
7.4.3. Eyelid Surgery
7.4.4. Liposuction
7.4.5. Tummy Tuck

8. Cosmetic Surgery Market, by Provider
8.1. Introduction
8.2. Hospitals & Specialty Clinics
8.3. Spas & Cosmetic Surgery Centers

9. Americas Cosmetic Surgery Market
9.1. Introduction
9.2. Argentina
9.3. Brazil
9.4. Canada
9.5. Mexico
9.6. United States

10. Asia-Pacific Cosmetic Surgery Market
10.1. Introduction
10.2. Australia
10.3. China
10.4. India
10.5. Indonesia
10.6. Japan
10.7. Malaysia
10.8. Philippines
10.9. Singapore
10.10. South Korea
10.11. Taiwan
10.12. Thailand
10.13. Vietnam

11. Europe, Middle East & Africa Cosmetic Surgery Market
11.1. Introduction
11.2. Denmark
11.3. Egypt
11.4. Finland
11.5. France
11.6. Germany
11.7. Israel
11.8. Italy
11.9. Netherlands
11.10. Nigeria
11.11. Norway
11.12. Poland
11.13. Qatar
11.14. Russia
11.15. Saudi Arabia
11.16. South Africa
11.17. Spain
11.18. Sweden
11.19. Switzerland
11.20. Turkey
11.21. United Arab Emirates
11.22. United Kingdom

12. Competitive Landscape
12.1. FPNV Positioning Matrix
12.1.1. Quadrants
12.1.2. Business Strategy
12.1.3. Product Satisfaction
12.2. Market Ranking Analysis, By Key Player
12.3. Market Share Analysis, By Key Player
12.4. Competitive Scenario
12.4.1. Merger & Acquisition
12.4.2. Agreement, Collaboration, & Partnership
12.4.3. New Product Launch & Enhancement
12.4.4. Investment & Funding
12.4.5. Award, Recognition, & Expansion

13. Company Usability Profiles
13.1. Adoderm GmbH
13.1.1. Business Overview
13.1.2. Key Executives
13.1.3. Product & Services
13.2. Aerolase Corp.
13.2.1. Business Overview
13.2.2. Key Executives
13.2.3. Product & Services
13.3. Aesthetic Dermal S.L.
13.3.1. Business Overview
13.3.2. Key Executives
13.3.3. Product & Services
13.4. Allergan, Inc.
13.4.1. Business Overview
13.4.2. Key Executives
13.4.3. Product & Services
13.5. Amiea Med
13.5.1. Business Overview
13.5.2. Key Executives
13.5.3. Product & Services
13.6. Anteis S.A.
13.6.1. Business Overview
13.6.2. Key Executives
13.6.3. Product & Services
13.7. BENEV Company Inc.
13.7.1. Business Overview
13.7.2. Key Executives
13.7.3. Product & Services
13.8. Canfield Imaging Systems
13.8.1. Business Overview
13.8.2. Key Executives
13.8.3. Product & Services
13.9. Chromomogenex PLC
13.9.1. Business Overview
13.9.2. Key Executives
13.9.3. Product & Services
13.10. Contura International A/S
13.10.1. Business Overview
13.10.2. Key Executives
13.10.3. Product & Services
13.11. Cutera, Inc.
13.11.1. Business Overview
13.11.2. Key Executives
13.11.3. Product & Services
13.12. Genesis Biosystems, Inc.
13.12.1. Business Overview
13.12.2. Key Executives
13.12.3. Product & Services
13.13. Johnson & Johnson
13.13.1. Business Overview
13.13.2. Key Executives
13.13.3. Product & Services
13.14. Syneron Medical Ltd.
13.14.1. Business Overview
13.14.2. Key Executives
13.14.3. Product & Services
13.15. Valeant Pharmaceuticals International
13.15.1. Business Overview
13.15.2. Key Executives
13.15.3. Product & Services

14. Appendix
14.1. Discussion Guide
14.2. License & Pricing